Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun

Hospira 00409490334 - McKesson Medical-Surgical

Cardinal 8881570300 - McKesson Medical-Surgical

AbbVie Inc 00074228203 - McKesson Medical-Surgical

Pfizer 00409177805 - McKesson Medical-Surgical

Ritedose Sodium Chloride for Inhalation 7% Unit Dose 4 mL Ampule

Pfizer Hospital US

Pfizer Hospital US

Pfizer 00409488850 - McKesson Medical-Surgical

News – The Ritedose Corporation

Press Releases – The Ritedose Corporation

The Ritedose Corporation